Mouse study identifies bile acid pathways that may reduce liver fat

Nonalcoholic fatty liver disease (NAFLD), now known as metabolic dysfunction-associated steatotic liver disease (MASLD), is a common condition that causes excess fat to build up in the liver, affecting about one-quarter of adults worldwide. In some people, this can lead to inflammation and hepatocyte injury, triggering the formation of thick, fibrous connective tissue known as fibrosis.

Read it at Medical Xpress ↗

← Front page